Detalhe da pesquisa
1.
Study protocol for a prospective, randomized, multicenter trial to investigate the influence of peripheral nerve stimulation on patients with chronic sacroiliac joint syndrome (SILENCING).
Trials
; 25(1): 223, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549128
2.
Human brain tumor imaging with a protein-binding MR contrast agent: initial experience.
Eur Radiol
; 20(1): 218-26, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19672603
3.
Correction: CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.
Cell Death Dis
; 11(7): 558, 2020 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699236
4.
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
J Clin Oncol
; 34(14): 1611-9, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976423
5.
A rare primary sellar melanoma. Case report.
J Neurosurg
; 100(5): 931-4, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15137611
6.
Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.
Invest Radiol
; 46(6): 390-400, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21285888
7.
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Invest Radiol
; 45(12): 755-68, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20829706
8.
Yes and PI3K bind CD95 to signal invasion of glioblastoma.
Cancer Cell
; 13(3): 235-48, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18328427